HomeVenture Capital

Venture Capital

Venture Capital

Nuclera Raises Series C Funding to $87 Million to Expand Antibody Engineering Platform

Life Sciences Times - 0
Venture Capital

MEDIPOST Secures $140 Million to Advance U.S. Phase III Stem Cell Trial

Life Sciences Times - 0
Venture Capital

Carna Health Raises $8 Million to Expand Global Chronic Kidney Disease Screening Programs

Life Sciences Times - 0
Venture Capital

Parabilis Medicines Raises $305 Million to Advance Zolucatetide and Helicon Platform

Life Sciences Times - 0
Venture Capital

Vizgen Raises $48 Million to Accelerate Spatial Multi-Omics Growth

Life Sciences Times - 0
Venture Capital

Corsera Health Raises $80 Million Series A and Begins First Clinical Trial

Life Sciences Times - 0
Venture Capital

Nocion Therapeutics Expands Series B to $93 Million to Advance Late-Stage Development of Taplucainium for Chronic Cough

Life Sciences Times - 0
Venture Capital

Prudentia Sciences Raises $20 Million Series A to Advance AI-Driven Due Diligence in Life Sciences Dealmaking

Life Sciences Times - 0
Pharma

Helus Pharma Rebrands and Begins Trading on Nasdaq as It Advances Mental Health Drug Portfolio

Life Sciences Times - 0
Venture Capital

Johnson & Johnson Completes Acquisition of Halda Therapeutics

Life Sciences Times - 0
Venture Capital

Startup Shutdowns Shift to Later Stages as First AI Reckoning Emerges, Report Finds

Life Sciences Times - 0
Venture Capital

Fulgent Genetics to Acquire Bako Diagnostics and StrataDx in $55.5 Million Deal

Life Sciences Times - 0
1...345...114Page 4 of 114

Most Read